PMID- 35171326 OWN - NLM STAT- MEDLINE DCOM- 20220803 LR - 20220803 IS - 1432-2307 (Electronic) IS - 0945-6317 (Linking) VI - 481 IP - 2 DP - 2022 Aug TI - Coamplification of 12q15 and 12p13 and homozygous CDKN2A/2B deletion: synergistic role of fibrosarcomatous transformation in dermatofibrosarcoma protuberans with a cryptic COL1A1-PDGFB fusion. PG - 313-319 LID - 10.1007/s00428-022-03297-5 [doi] AB - Dermatofibrosarcoma protuberans (DFSP) is characterized by collagen type I alpha 1 chain-platelet-derived growth factor B chain (COL1A1-PDGFB) fusion. We present a case of fibrosarcomatous DFSP with lung metastasis in a 53-year-old man. Histologically, the primary and metastatic tumors were composed of high-grade fibrosarcomatous component with varying myxoid changes, while only a small focus of the classic DFSP element was identified in the primary lesion. No evidence of COL1A1-PDGFB fusion was identified by routine fluorescence in situ hybridization (FISH). Subsequent next-generation sequencing and COL1A1 break-apart FISH identified the fusion. In addition, coamplification of 12q15 and 12p13, along with CDKN2A/2B deletion, was confirmed to be limited to the fibrosarcomatous component. The current case is a novel FS-DFSP with cryptic COL1A1-PDGFB fusion. This is the first published example of DFSP harboring coamplification of 12q and 12p sequences. More importantly, the genetic aberrations restricted to the fibrosarcomatous component indicated a synergistic role of higher-grade progression. CI - (c) 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. FAU - Lu, Yang AU - Lu Y AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, 610041, Sichuan, China. FAU - Li, Tao AU - Li T AD - Department of Pathology, Pujiang County People's Hospital, Chengdu, China. FAU - Chen, Min AU - Chen M AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, 610041, Sichuan, China. FAU - Peng, Heng AU - Peng H AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, 610041, Sichuan, China. FAU - Du, Tianhai AU - Du T AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, 610041, Sichuan, China. FAU - Qiu, Yan AU - Qiu Y AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, 610041, Sichuan, China. FAU - Zhang, Hongying AU - Zhang H AUID- ORCID: 0000-0003-4748-4121 AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, 610041, Sichuan, China. hy_zhang@scu.edu.cn. LA - eng PT - Case Reports PT - Journal Article DEP - 20220216 PL - Germany TA - Virchows Arch JT - Virchows Archiv : an international journal of pathology JID - 9423843 RN - 0 (CDKN2A protein, human) RN - 0 (Collagen Type I, alpha 1 Chain) RN - 0 (Cyclin-Dependent Kinase Inhibitor p16) RN - 0 (Oncogene Proteins, Fusion) RN - 0 (Proto-Oncogene Proteins c-sis) SB - IM MH - Collagen Type I, alpha 1 Chain MH - Cyclin-Dependent Kinase Inhibitor p16/genetics MH - *Dermatofibrosarcoma/genetics/metabolism/pathology MH - Humans MH - In Situ Hybridization, Fluorescence MH - Oncogene Proteins, Fusion/genetics MH - Proto-Oncogene Proteins c-sis/genetics MH - *Skin Neoplasms/pathology OTO - NOTNLM OT - 12p amplification OT - COL1A1-PDGFB fusion OT - Dermatofibrosarcoma protuberans OT - Fibrosarcomatous transformation OT - MDM2 amplification EDAT- 2022/02/17 06:00 MHDA- 2022/08/04 06:00 CRDT- 2022/02/16 12:16 PHST- 2021/11/22 00:00 [received] PHST- 2022/02/04 00:00 [accepted] PHST- 2022/01/31 00:00 [revised] PHST- 2022/02/17 06:00 [pubmed] PHST- 2022/08/04 06:00 [medline] PHST- 2022/02/16 12:16 [entrez] AID - 10.1007/s00428-022-03297-5 [pii] AID - 10.1007/s00428-022-03297-5 [doi] PST - ppublish SO - Virchows Arch. 2022 Aug;481(2):313-319. doi: 10.1007/s00428-022-03297-5. Epub 2022 Feb 16.